Abstract: A display includes micro LEDs connected to a color conversion layer and driver ICs connected to the micro LEDs via an electrically connecting layer. Each micro LEDs includes an N pad and a P pad. The micro LEDs emit light of a same color, and the color conversion layer converts the light into various colors. The electrically connecting layer includes elongated negative electrodes connected to the N pads and elongated positive electrodes connected to the P pads. Each driver IC includes a first group of bonding pads on a face, a second group of bonding pads on an opposite face, and conductors for connecting the first group of bonding pads to the second group of bonding pads. Each bonding pad in the first group is connected to an elongated negative or positive electrode. The circuit board is connected to the second group of bonding pads of each driver IC.

Abstract: A storage apparatus includes non-volatile memory cells formed on a memory die, each memory cell configured to hold bits of data, and a control circuit. The control circuit is configured to calculate parity data for data to be stored in the memory cells and program the memory cells to first distributions. The control circuit is also configured to read memory cells in the first distributions, recover the data from results of reading the memory cells in the first distributions combined with the parity data, and further program the memory cells from the first distributions to second distributions to store the data. To improve the accuracy of recovering the encoded foggy phase data, techniques are presented to calibrate the voltage levels used in sensing the foggy state distributions.

Abstract: A storage apparatus includes non-volatile memory cells formed on a memory die, each memory cell configured to hold bits of data, and a control circuit formed on the memory die. The control circuit is configured to calculate parity data for data to be stored in the memory cells and program the memory cells to first distributions. The control circuit is also configured to read memory cells in the first distributions, recover the data from results of reading the memory cells in the first distributions combined with the parity data, and further program the memory cells from the first distributions to second distributions to store the data. In some cases, the recovered data may have a high bit error rate. To handle higher bit error rates, the use of soft bit data is incorporated into an encoded foggy-fine scheme.

Abstract: A touch panel includes a display substrate, pixel units supported on the display substrate, an electronic circuit for electrically connecting the pixel units to one another, and a molded resin portion for enclosing the pixel units. Each of the pixel units includes three miniature light-emitting diodes for emitting red light, green light and blue light respectively, a sensor, and a driver integrated circuit electrically connected to the miniature light-emitting diodes and the sensor.

Abstract: A pneumatic nail gun includes a gun body, a muzzle connected to the gun body for receiving a nail, a cylinder unit disposed in the gun body, an air valve unit having a cover portion, and a striking unit having a piston. The cylinder unit includes a gas storage chamber, a striking cylinder having a cylinder chamber 510 in fluid communication with the gas storage chamber, and at least one gas storage cylinder in fluid communication with the gas storage chamber for receiving a gas having a pre-determined gas pressure. The cover portion is operable to interrupt fluid communication between the cylinder chamber and the gas storage chamber, and to allow the fluid communication such that the piston is pushed by the gas to strike the nail.

Abstract: An active fluid static elimination system installed in a fluid transportation pipeline includes a solenoid valve, an electrostatic measuring device, a fluid destaticizer, and a controller. The solenoid valve is connected to a connecting port of the fluid transportation pipeline, and the electrostatic measuring device is used to measure an electrostatic value of a fluid in the fluid transportation pipeline. The fluid destaticizer is connected to the solenoid valve, and the controller is connected to the electrostatic measuring device and the solenoid valve. The solenoid valve is opened to allow the fluid passing through the fluid destaticizer to eliminate the electrostatic charge of the fluid when the controller determines that the electrostatic value measured by the electrostatic measuring device is greater than a predetermined value.

Abstract: The invention provides CARs (CARs) that specifically bind to BCMA (B-Cell Maturation Antigen). The invention further relates to engineered immune cells comprising such CARs, CAR-encoding nucleic acids, and methods of making such CARs, engineered immune cells, and nucleic acids. The invention further relates to therapeutic methods for use of these CARs and engineered immune cells for the treatment of a condition associated with malignant cells expressing BCMA (e.g., cancer).

Abstract: An apparatus and method simulates cable routing for determining signal integrity between electronic components within a computer chassis. The apparatus includes a base plate simulating a computer chassis base. The base plate includes a top surface. A plurality of reconfigurable mounting fixtures each allow temporary mounting of a printed circuit board assembly (PCBA) to a respective reconfigurable mounting fixture. The plurality of reconfigurable mounting fixtures is temporarily mountable anywhere on the top surface of the base plate. A cable including a first end connector allows a connection to a first PCBA, and a second end connector allows a connection to a second PCBA.

Abstract: Provided herein, inter alia, are isolated, humanized antibodies that bind an extracellular domain of a human SIRP-? polypeptide. Also provided are polynucleotides, vectors, host cells, and methods of production and use related thereto.

Abstract: Provided herein is a conjugate for modulating a natural killer cell or myeloid cell, comprising a targeting moiety and an immunomodulating polynucleotide. Also provided herein is a pharmaceutical composition for modulating a natural killer cell or myeloid cell, comprising a conjugate comprising a targeting moiety and an immunomodulating polynucleotide, and a pharmaceutically acceptable excipient. Additionally provided herein are methods of their use for modulating a natural killer cell or myeloid cell and treating a proliferative disease.

Abstract: The present disclosure describes various exemplary memory storage devices that can be programmed to write electronic data into one or more memory cells in a write mode of operation and/or to read the electronic data from the one or more memory cells in a read mode of operation. The various exemplary memory storage devices can select various control lines to read the electronic data from the one or more memory cells onto data lines and/or to write the electronic data from these data lines into the one or more memory cells. In some situations, these data lines are charged, also referred to as pre-charged, to a first logical value, such as a logical one, before the various exemplary memory storage devices write the electronic data into the one or more memory cells. During this pre-charging of these data lines, the various exemplary memory storage devices electrically isolate these data lines from specialized circuitry within these exemplary memory storage devices.

Abstract: A method for making a light-emitting device includes providing a driver IC wafer with multiple control circuits. Groups of tiny light-emitting diodes are stacked on the driver IC wafer and electrically connected to the control circuits. Each of the groups comprises a tiny light-emitting diode for emitting red light, a tiny light-emitting diode for emitting green light and a tiny light-emitting diode for emitting blue light. The groups of tiny light-emitting diodes on the driver IC wafer are packaged. The driver IC wafer is cut into driver integrated circuits. Each of the driver integrated circuits includes one of the control circuits electrically connected to one of the groups of tiny light-emitting diodes. Thus, pixel units are provided. The pixel units are transferred to a display substrate and the control circuits of the pixel units are connected to a circuit of the display substrate. Thus, a single light-emitting device is provided.

Abstract: A heat conductive device includes a heat conductive unit, a wick structure, a heat transferring unit, and a heat conductive fluid. The heat conductive unit has a closed chamber. The wick structure is disposed on the inner side surface of the closed chamber. The heat transferring unit includes a plurality of heat conductive elements agglomerated into islands and separated from each other. The heat conductive elements are disposed on the partial surface of the wick structure. The heat conductive fluid is disposed in the closed chamber. An electronic device including the heat conductive device is also provided. The heat conductive device has a good heat conductive efficiency.

Abstract: Provided herein, inter alia, are isolated antibodies that bind an extracellular domain of a human SIRP-? v1 polypeptide (e.g., the D1 domain), an extracellular domain of a human SIRP-? v2 polypeptide, or both. In some embodiments, the antibodies also bind an extracellular domain of a monkey SIRP-? polypeptide, an extracellular domain of a mouse SIRP-? polypeptide, an extracellular domain of a human SIRP-? polypeptide, and/or an extracellular domain of a human SIRP-? polypeptide. In some embodiments, the antibodies block or do not binding between an extracellular domain of a human SIRP-? polypeptide and an IgSF domain of a human CD47 polypeptide, while in some embodiments, the antibodies reduce the affinity of a human SIRP-? polypeptide for binding an IgSF domain of a human CD47 polypeptide. Further provided herein are methods, polynucleotides, vectors, and host cells related thereto.

Abstract: Provided herein, inter alia, are isolated antibodies that bind an extracellular domain of a human SIRP-? v1 polypeptide (e.g., the D1 domain), an extracellular domain of a human SIRP-? v2 polypeptide, or both. In some embodiments, the antibodies also bind an extracellular domain of a monkey SIRP-? polypeptide, an extracellular domain of a mouse SIRP-? polypeptide, an extracellular domain of a human SIRP-? polypeptide, and/or an extracellular domain of a human SIRP-? polypeptide. In some embodiments, the antibodies block or do not binding between an extracellular domain of a human SIRP-? polypeptide and an IgSF domain of a human CD47 polypeptide, while in some embodiments, the antibodies reduce the affinity of a human SIRP-? polypeptide for binding an IgSF domain of a human CD47 polypeptide. Further provided herein are methods, polynucleotides, vectors, and host cells related thereto.

Abstract: The present disclosure features signal-regulatory protein ? (SIRP-?) polypeptides and constructs that are useful, e.g., to target a cell (e.g., a cancer cell or a cell of the immune system), to increase phagocytosis of the target cell, to eliminate immune cells such as regulatory T-cells, to kill cancer cells, to treat a disease (e.g., cancer) in a subject, or any combinations thereof. The SIRP-? constructs include a high affinity SIRP-? D1 domain or variant thereof that binds CD47 with higher affinity than a wild-type SIRP-?. The SIRP-? polypeptides or constructs include a SIRP-? D1 variant fused to an Fc domain monomer, a human serum albumin (HSA), an albumin-binding peptide, or a polyethylene glycol (PEG) polymer. Compositions provided herein include (i) a polypeptide including a signal-regulatory protein ? (SIRP-?) D1 variant and (ii) an antibody.

Abstract: A multifunction cap replacement module includes a cap rotation module supporter and at least one cap rotation module. The cap rotation module is mounted to the cap rotation module supporter, and the cap rotation module includes a first cap rotation device and a second cap rotation device. The first cap rotation device is configured to open one sealing cap of at least one chemical drum and extract a chemical liquid from the chemical drum, and the second cap rotation device is configured to open another one sealing cap of the chemical drum and allow the chemical liquid to flow back to the chemical drum.

Abstract: A fluid destaticizer includes a valve main body, a one-way check valve, a discharge vessel, and an electrostatic discharger. The one-way check valve is installed in the valve main body, the discharge vessel is provided in the valve main body, and the discharge vessel is connected to the one-way check valve. In addition, the discharge vessel includes a sidewall, and the electrostatic discharger is installed on the sidewall of the discharge vessel to discharge the electrostatic charge in the fluid and the fluid is exhausted from the valve main body through the discharge vessel.

Abstract: An active fluid static elimination system installed in a fluid transportation pipeline includes a solenoid valve, an electrostatic measuring device, a fluid destaticizer, and a controller. The solenoid valve is connected to a connecting port of the fluid transportation pipeline, and the electrostatic measuring device is used to measure an electrostatic value of a fluid in the fluid transportation pipeline. The fluid destaticizer is connected to the solenoid valve, and the controller is connected to the electrostatic measuring device and the solenoid valve. The solenoid valve is opened to allow the fluid passing through the fluid destaticizer to eliminate the electrostatic charge of the fluid when the controller determines that the electrostatic value measured by the electrostatic measuring device is greater than a predetermined value.

Abstract: Provided herein, inter alia, are isolated antibodies that bind an extracellular domain of a human SIRP-? v1 polypeptide (e.g., the D1 domain), an extracellular domain of a human SIRP-? v2 polypeptide or both. In some embodiments, the antibodies also bind an extracellular domain of a monkey SIRP-? polypeptide, an extracellular domain of a SIRP-? polypeptide, an extracellular domain of a human SIRP-? polypeptide, and/or an extracellular domain of a human SIRP-? polypeptide. In some embodiments, the antibodies block or do not binding between an extracellular domain of a human SIRP-? polypeptide and an IgSF domain of a human CD47 polypeptide, while in some embodiments, the antibodies reduce the affinity of a human SIRP-? polypeptide for binding an IgSF domain of a human CD47 polypeptide. Further provided herein are methods, polynucleotides, vectors, and host cells related thereto.